- BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling
-
Chao A, Lin YH, Yang LY, Wu RC, Chang WY, Chang PY, Chang SC, Lin CY, Huang HJ, Lin CT, Chou HH, Huang KG, Kuo WL, Chang TC, Lai CH
- KMID: 2500476
- J Gynecol Oncol.
- 2020 Apr;31(3):e24.
- doi: 10.3802/jgo.2020.31.e24
Objective: The characteristics of patients with metachronous breast and ovarian malignancies and the pathogenic role of BRCA1/2 mutations remain poorly understood. We investigated these issues through a review of hospital... -
- CITED
-
- Close
- SHARE
-
- Close
- Maintenance of ovarian function in end-of-life cervical cancer patient following primary surgico-radiotherapy and ovarian transposition
-
Sicam RV, Huang KG, Chang YC, Lee CL
- KMID: 2288552
- J Gynecol Oncol.
- 2013 Apr;24(2):204-207.
- doi: 10.3802/jgo.2013.24.2.204
A 35-year-old woman underwent laparoscopic radical hysterectomy, pelvic lymphadenectomy and ovarian transposition for stage IB2 cervical adenocarcinoma. She received adjuvant concurrent chemoradiation for poor pathologic risk factors but had tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group
-
Lai CH, Vallikad E, Lin H, Yang LY, Jung SM, Liu HE, Ou YC, Chou HH, Lin CT, Huang HJ, Huang KG, Qiu J, Hung YC, Wu TI, Chang WY, Tan KT, Lin CY, Chao A, Chang CJ
- KMID: 2500404
- J Gynecol Oncol.
- 2020 Jan;31(1):e5.
- doi: 10.3802/jgo.2020.31.e5
Objectives: An Asian Gynecologic Oncology Group phase III randomized trial was conducted to determine whether maintenance chemotherapy could improve progression-free survival (PFS) in stages III/IV ovarian cancer. Methods: Between 2007 and... -
- CITED
-
- Close
- SHARE
-
- Close
